ID: ALA4443738

Max Phase: Preclinical

Molecular Formula: C54H58O18

Molecular Weight: 995.04

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  COc1c(C)c(OC(=O)c2c(C)c(C)c(OC(=O)c3c(C)c(C(=O)Oc4c(C)c(C)c(C(=O)Oc5c(C)c(C)c(C(=O)O)c(OC)c5C)c(OC)c4C)c(O)c(C)c3O)c(C)c2OC)c(C)c(C)c1C(=O)O

Standard InChI:  InChI=1S/C54H58O18/c1-19-23(5)41(29(11)45(65-15)35(19)49(57)58)71-53(63)37-21(3)25(7)43(31(13)47(37)67-17)69-51(61)33-27(9)34(40(56)28(10)39(33)55)52(62)70-44-26(8)22(4)38(48(68-18)32(44)14)54(64)72-42-24(6)20(2)36(50(59)60)46(66-16)30(42)12/h55-56H,1-18H3,(H,57,58)(H,59,60)

Standard InChI Key:  NGJHUXZYCZQDOD-UHFFFAOYSA-N

Associated Targets(Human)

Proteasome assembly chaperone 3 51 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

PAC1-PAC2 complex 49 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 995.04Molecular Weight (Monoisotopic): 994.3623AlogP: 9.72#Rotatable Bonds: 14
Polar Surface Area: 257.18Molecular Species: ACIDHBA: 16HBD: 4
#RO5 Violations: 3HBA (Lipinski): 18HBD (Lipinski): 4#RO5 Violations (Lipinski): 3
CX Acidic pKa: 3.48CX Basic pKa: CX LogP: 15.18CX LogD: 8.63
Aromatic Rings: 5Heavy Atoms: 72QED Weighted: 0.06Np Likeness Score: 0.35

References

1. Ohsawa K, Yoshida M, Izumikawa M, Takagi M, Shin-Ya K, Goshima N, Hirokawa T, Natsume T, Doi T..  (2018)  Synthesis and biological evaluation of thielocin B1 analogues as protein-protein interaction inhibitors of PAC3 homodimer.,  26  (23-24): [PMID:30455074] [10.1016/j.bmc.2018.11.001]

Source